Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.34 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12173074 | 0.90 | SMN1; SMN2 (0.38) | MAPTALDH1A1TP53GAAHPGD | |
| SCHEMBL20390575 | 0.85 | FUT8 (0.40) | MAPTALDH1A1FUT8P2RX3 | |
| SCHEMBL13764095 | 0.83 | FUT8 (0.38) | MAPTALDH1A1FUT8P2RX3 | |
| SCHEMBL12053415 | 0.80 | FUT8 (0.38) | FUT8P2RX3 | |
| SCHEMBL13763511 | 0.77 | CAMK2D (0.31) | FUT8 | |
| SCHEMBL12646575 | 0.77 | FUT8 (0.38) | FUT8 | |
| SCHEMBL12173082 | 0.77 | FUT8 (0.38) | FUT8 | |
| SCHEMBL12189778 | 0.76 | FUT8 (0.39) | FUT8P2RX3 | |
| SCHEMBL10017408 | 0.76 | FUT8 (0.47) | MAPTALDH1A1FUT8 | |
| SCHEMBL16626829 | 0.76 | FUT8 (0.40) | FUT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| WO-2010149505-A2 | CHARGED PARTICLES | BASF SE (DE) | 2010-12-29 | — | — | WO | disclosed |
| US-20100016519-A1 | COLORED ORGANOPOLYSILOXANES | DYSTAR COLOURS DEUTSCHLAND GMBH (DE) | 2010-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | APP 2706/4885MAPT 2632/4885SNCA 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.